Related references
Note: Only part of the references are listed.Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection
Brandon J. Webb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis
Jessie Signorelli et al.
TRANSPLANT INFECTIOUS DISEASE (2020)
Optimal Management of Neutropenic Fever in Patients With Cancer
Andrea J. Zimmer et al.
JOURNAL OF ONCOLOGY PRACTICE (2019)
Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study
Lenaig Le Clech et al.
INFECTIOUS DISEASES (2018)
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial
Manuela Aguilar-Guisado et al.
LANCET HAEMATOLOGY (2017)
Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review
Matthew Snyder et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group
Diana Averbuch et al.
CLINICAL INFECTIOUS DISEASES (2017)
Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient?
Jessica R. Galloway-Pena et al.
CLINICAL CANCER RESEARCH (2017)
Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation
Daniela Weber et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Prevention and Treatment of Cancer-Related Infections, Version 2.2016
Lindsey Robert Baden et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Evaluation of empiric antibiotic de-escalation in febrile neutropenia
Amanda L. Kroll et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2016)
Levofloxacin Versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation
Vi Phuong Doan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease
Ernst Holler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
The current spectrum of infection in cancer patients with chemotherapy related neutropenia
Lior Nesher et al.
INFECTION (2014)
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia
Diana Averbuch et al.
HAEMATOLOGICA (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: A prospective observational safety study
Lennert Slobbe et al.
EUROPEAN JOURNAL OF CANCER (2009)
Bacteraernia in febrile neutropenic cancer patients
J. Klastersky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies
H Çelebi et al.
BONE MARROW TRANSPLANTATION (2000)
Randomized placebo-controlled trial of oral antibiotics in pediatric oncology patients at low-risk with fever and neutropenia
RJ Klaassen et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2000)
Share Paper
